{
  "PMC": "3933076",
  "DOI": "10.1111/j.1582-4934.2006.tb00526.x",
  "PMID": "17125586",
  "PMCID": "PMC3933076",
  "title": "X-linked mental retardation and epigenetics.",
  "year": 2006,
  "source_url": "https://europepmc.org/article/PMC/PMC3933076",
  "source": "MED",
  "abstract_text": "The search for the genetic defects in constitutional diseases has so far been restricted to direct methods for the identification of genetic mutations in the patients' genome. Traditional methods such as karyotyping, FISH, mutation screening, positional cloning and CGH, have been complemented with newer methods including array-CGH and PCR-based approaches (MLPA, qPCR). These methods have revealed a high number of genetic or genomic aberrations that result in an altered expression or reduced functional activity of key proteins. For a significant percentage of patients with congenital disease however, the underlying cause has not been resolved strongly suggesting that yet other mechanisms could play important roles in their etiology. Alterations of the 'native' epigenetic imprint might constitute such a novel mechanism. Epigenetics, heritable changes that do not rely on the nucleotide sequence, has already been shown to play a determining role in embryonic development, X-inactivation, and cell differentiation in mammals. Recent progress in the development of techniques to study these processes on full genome scale has stimulated researchers to investigate the role of epigenetic modifications in cancer as well as in constitutional diseases. We will focus on mental impairment because of the growing evidence for the contribution of epigenetics in memory formation and cognition. Disturbance of the epigenetic profile due to direct alterations at genomic regions, or failure of the epigenetic machinery due to genetic mutations in one of its components, has been demonstrated in cognitive derangements in a number of neurological disorders now. It is therefore tempting to speculate that the cognitive deficit in a significant percentage of patients with unexplained mental retardation results from epigenetic modifications.",
  "full_text": "J Cell Mol Med J. Cell. Mol. Med jcmm Journal of Cellular and Molecular Medicine 1582-1838 1582-4934 John Wiley & Sons, Ltd Chichester, UK 3933076 17125586 10.1111/j.1582-4934.2006.tb00526.x Epigenetic Review Series X-linked mental retardation and epigenetics Froyen Guy * Bauters Marijke Voet Thierry Marynen Peter Human Genome Laboratory, VIB, Department Molecular and Developmental Genetics, University of Leuven Belgium * Correspondence to: Dr. Guy FROYEN Human Genome Laboratory, VIB, Dept. Molecular and Developmental Genetics, Herestraat 49, University of Leuven, B-3000 Leuven, Belgium. Tel.: 16-330130; Fax: 16-347166 E-mail: guy.froyen@med.kuleuven.be Guest Editor: J.J. Cassiman 10 2006 09 10 2008 10 4 808 825 20 9 2006 23 10 2006 The search for the genetic defects in constitutional diseases has so far been restricted to direct methods for the identification of genetic mutations in the patients’ genome. Traditional methods such as karyotyping, FISH, mutation screening, positional cloning and CGH, have been complemented with newer methods including array-CGH and PCR-based approaches (MLPA, qPCR). These methods have revealed a high number of genetic or genomic aberrations that result in an altered expression or reduced functional activity of key proteins. For a significant percentage of patients with congenital disease however, the underlying cause has not been resolved strongly suggesting that yet other mechanisms could play important roles in their etiology. Alterations of the ‘native’ epigenetic imprint might constitute such a novel mechanism. Epigenetics, heritable changes that do not rely on the nucleotide sequence, has already been shown to play a determining role in embryonic development, X-inactivation, and cell differentiation in mammals. Recent progress in the development of techniques to study these processes on full genome scale has stimulated researchers to investigate the role of epigenetic modifications in cancer as well as in constitutional diseases. We will focus on mental impairment because of the growing evidence for the contribution of epigenetics in memory formation and cognition. Disturbance of the epigenetic profile due to direct alterations at genomic regions, or failure of the epigenetic machinery due to genetic mutations in one of its components, has been demonstrated in cognitive derangements in a number of neurological disorders now. It is therefore tempting to speculate that the cognitive deficit in a significant percentage of patients with unexplained mental retardation results from epigenetic modifications. epigenetics acetylation methylation chromatin mental retardation X-linked memory References 1 Robinson PJ Rhodes D Structure of the ’30 nm’ chromatin fibre: a key role for the linker histone Curr Opin Struct Biol 2006 16 336 43 16714106 2 Saeki H Ohsumi K Aihara H Ito T Hirose S Ura K Kaneda Y Linker histone variants control chromatin dynamics during early embryogenesis Proc Natl Acad Sci USA 2005 102 5697 702 15821029 3 Loden M van Steensel B Whole-genome views of chromatin structure Chromosome Res 2005 13 289 98 15868422 4 Ringrose L Paro R Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins Annu Rev Genet 2004 38 413 43 15568982 5 Klose RJ Bird AP Genomic DNA methylation: the mark and its mediators Trends Biochem Sci 2006 31 89 97 16403636 6 Nan X Ng HH Johnson CA Laherty CD Turner BM Eisenman RN Bird A Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex Nature 1998 393 386 9 9620804 7 Okano M Li E Genetic analyses of DNA methyltransferase genes in mouse model system J Nutr 2002 132 2462S 5S 12163712 8 Okano M Xie S Li E Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells Nucleic Acids Res 1998 26 2536 40 9592134 9 Fan Y Nikitina T Zhao J Fleury TJ Bhattacharyya R Bouhassira EE Stein A Woodcock CL Skoultchi AI Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation Cell 2005 123 1199 212 16377562 10 Rupp RA Becker PB Gene regulation by histone H1: new links to DNA methylation Cell 2005 123 1178 9 16377556 11 Robertson KD DNA methylation and human disease Nat Rev Genet 2005 6 597 610 16136652 12 Das PM Singal R DNA methylation and cancer J Clin Oncol 2004 22 4632 42 15542813 13 Ballestar E Esteller M Methyl-CpG-binding proteins in cancer: blaming the DNA methylation messenger Biochem Cell Biol 2005 83 374 84 15959563 14 Egger G Liang G Aparicio A Jones PA Epigenetics in human disease and prospects for epigenetic therapy Nature 2004 429 457 63 15164071 15 Schofield PN Joyce JA Lam WK Grandjean V Ferguson-Smith A Reik W Maher ER Genomic imprinting and cancer; new paradigms in the genetics of neoplasia Toxicol Lett 2001 120 151 60 11323172 16 Nicholls RD Saitoh S Horsthemke B Imprinting in Prader-Willi and Angelman syndromes Trends Genet 1998 14 194 200 9613204 17 Fuks F DNA methylation and histone modifications: teaming up to silence genes Curr Opin Genet Dev 2005 15 490 5 16098738 18 Cho KS Elizondo LI Boerkoel CF Advances in chromatin remodeling and human disease Curr Opin Genet Dev 2004 14 308 15 15172675 19 Esteller M Almouzni G How epigenetics integrates nuclear functions. Workshop on epigenetics and chromatin: transcriptional regulation and beyond EMBO Rep 2005 6 624 8 15976819 20 Roberts CW Orkin SH The SWI/SNF complex—chro-matin and cancer Nat Rev Cancer 2004 4 133 42 14964309 21 Strahl BD Allis CD The language of covalent histone modifications Nature 2000 403 41 5 10638745 22 Jenuwein T Allis CD Translating the histone code Science 2001 293 1074 80 11498575 23 Dutnall RN Cracking the histone code: one, two, three methyls, you’re out! Mol Cell 2003 12 3 4 12887887 24 Devi BJ Schneeweiss FH Sharan RN Negative correlation between poly-ADP-ribosylation of spleen cell his-tone proteins and initial duration of dimethylnitrosamine exposure to mice in vivo measured by Western blot immunoprobe assay: a possible biomarker for cancer detection Cancer Detect Prev 2005 29 66 71 15734220 25 Cohen-Armon M Visochek L Katzoff A Levitan D Susswein AJ Klein R Valbrun M Schwartz JH Long-term memory requires polyADP-ribosylation Science 2004 304 1820 2 15205535 26 Visochek L Steingart RA Vulih-Shultzman I Klein R Priel E Gozes I Cohen-Armon M PolyADP-ribosylation is involved in neurotrophic activity J Neurosci 2005 25 7420 8 16093393 27 Kraus WL Lis JT PARP goes transcription Cell 2003 113 677 83 12809599 28 Lieb JD Beck S Bulyk ML Farnham P Hattori N Henikoff S Liu XS Okumura K Shiota K Ushijima T Greally JM Applying whole-genome studies of epigenetic regulation to study human disease Cytogenet Genome Res 2006 114 1 15 16717444 29 Perini G Tupler R Altered gene silencing and human diseases Clin Genet 2006 69 1 7 16451126 30 Rodenhiser D Mann M Epigenetics and human disease: translating basic biology into clinical applications CMAJ 2006 174 341 8 16446478 31 Peterson CL Laniel MA Histones and histone modifications Curr Biol 2004 14 R546 51 15268870 32 Brinkman AB Roelofsen T Pennings SW Martens JH Jenuwein T Stunnenberg HG Histone modification patterns associated with the human X chromosome EMBO Rep 2006 7 628 34 16648823 33 Shi Y Lan F Matson C Mulligan P Whetstine JR Cole PA Casero RA Shi Y Histone demethylation mediated by the nuclear amine oxidase homolog LSD1 Cell 2004 119 941 53 15620353 34 Tsukada Y Fang J Erdjument-Bromage H Warren ME Borchers CH Tempst P Zhang Y Histone demethylation by a family of JmjC domain-containing proteins Nature 2006 439 811 6 16362057 35 Klose RJ Kallin EM Zhang Y JmjC-domain-containing proteins and histone demethylation Nat Rev Genet 2006 7 715 27 16983801 36 Heard E Disteche CM Dosage compensation in mammals: fine-tuning the expression of the X chromosome Genes Dev 2006 20 1848 67 16847345 37 Okamoto I Arnaud D Le Baccon P Otte AP Disteche CM Avner P Heard E Evidence for de novo imprinted X-chromosome inactivation independent of meiotic inacti-vation in mice Nature 2005 438 369 73 16227973 38 Xu N Tsai CL Lee JT Transient homologous chromosome pairing marks the onset of X inactivation Science 2006 311 1149 52 16424298 39 Bacher CP Guggiari M Brors B Augui S Clerc P Avner P Eils R Heard E Transient colocalization of X-inactivation centres accompanies the initiation of X inactivation Nat Cell Biol 2006 8 293 9 16434960 40 Bernstein E Allis CD RNA meets chromatin Genes Dev 2005 19 1635 55 16024654 41 Maue RA Kraner SD Goodman RH Mandel G Neuron-specific expression of the rat brain type II sodium channel gene is directed by upstream regulatory elements Neuron 1990 4 223 31 2155009 42 Mori N Schoenherr C Vandenbergh DJ Anderson DJ A common silencer element in the SCG10 and type II Na + channel genes binds a factor present in nonneuronal cells but not in neuronal cells Neuron 1992 9 45 54 1321646 43 Huang Y Myers SJ Dingledine R Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes Nat Neurosci 1999 2 867 72 10491605 44 Naruse Y Aoki T Kojima T Mori N Neural restrictive silencer factor recruits mSin3 and histone deacetylase complex to repress neuron-specific target genes Proc Natl Acad Sci USA 1999 96 13691 6 10570134 45 Ballas N Battaglioli E Atouf F Andres ME Chenoweth J Anderson ME Burger C Moniwa M Davie JR Bowers WJ Federoff HJ Rose DW Rosenfeld MG Brehm P Mandel G Regulation of neuronal traits by a novel transcriptional complex Neuron 2001 31 353 65 11516394 46 Battaglioli E Andres ME Rose DW Chenoweth JG Rosenfeld MG Anderson ME Mandel G REST repression of neuronal genes requires components of the hSWI.SNF complex J Biol Chem 2002 277 41038 45 12192000 47 Lee MG Wynder C Cooch N Shiekhattar R An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation Nature 2005 437 432 5 16079794 48 Ballas N Grunseich C Lu DD Speh JC Mandel G REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis Cell 2005 121 645 57 15907476 49 Ballas N Mandel G The many faces of REST oversee epigenetic programming of neuronal genes Curr Opin Neurobiol 2005 15 500 6 16150588 50 Kim MY Jeong BC Lee JH Kee HJ Kook H Kim NS Kim YH Kim JK Ahn KY Kim KK A repressor complex, AP4 transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells Proc Natl Acad Sci USA 2006 103 13074 9 16924111 51 Santos M Coelho PA Maciel P Chromatin remodeling and neuronal function: exciting links Genes Brain Behav 2006 5 80 91 16681803 52 Ben-Porath I Cedar H Imprinting: focusing on the center Curr Opin Genet Dev 2000 10 550 4 10980434 53 Reik W Walter J Genomic imprinting: parental influence on the genome Nat Rev Genet 2001 2 21 32 11253064 54 Lewis A Reik W How imprinting centres work Cytogenet Genome Res 2006 113 81 9 16575166 55 Nicholls RD Knepper JL Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes Annu Rev Genomics Hum Genet 2001 2 153 75 11701647 56 Weksberg R Smith AC Squire J Sadowski P Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development Hum Mol Genet 2003 12 R61 8 12668598 57 Soejima H Wagstaff J Imprinting centers, chromatin structure, and disease J Cell Biochem 2005 95 226 33 15779004 58 Kishino T Imprinting in neurons Cytogenet Genome Res 2006 113 209 14 16575182 59 Guidotti A Auta J Davis JM Di-Giorgi-Gerevini V Dwivedi Y Grayson DR Impagnatiello F Pandey G Pesold C Sharma R Uzunov D Costa E Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study Arch Gen Psychiatry 2000 57 1061 9 11074872 60 Impagnatiello F Guidotti AR Pesold C Dwivedi Y Caruncho H Pisu MG Uzunov DP Smalheiser NR Davis JM Pandey GN Pappas GD Tueting P Sharma RP Costa E A decrease of reelin expression as a putative vulnerability factor in schizophrenia Proc Natl Acad Sci USA 1998 95 15718 23 9861036 61 Dong E Caruncho H Liu WS Smalheiser NR Grayson DR Costa E Guidotti A A reelin-integrin receptor interaction regulates Arc mRNA translation in synaptoneurosomes Proc Natl Acad Sci USA 2003 100 5479 84 12707415 62 Veldic M Caruncho HJ Liu WS Davis J Satta R Grayson DR Guidotti A Costa E DNA-methyltransferase 1 mRNA is selectively overexpressed in telen-cephalic GABAergic interneurons of schizophrenia brains Proc Natl Acad Sci USA 2004 101 348 53 14684836 63 Tremolizzo L Carboni G Ruzicka WB Mitchell CP Sugaya I Tueting P Sharma R Grayson DR Costa E Guidotti A An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability Proc Natl Acad Sci USA 2002 99 17095 100 12481028 64 Noh JS Sharma RP Veldic M Salvacion AA Jia X Chen Y Costa E Guidotti A Grayson DR DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures Proc Natl Acad Sci USA 2005 102 1749 54 15671176 65 Tremolizzo L Doueiri MS Dong E Grayson DR Davis J Pinna G Tueting P Rodriguez-Menendez V Costa E Guidotti A Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice Biol Psychiatry 2005 57 500 9 15737665 66 Abdolmaleky HM Cheng KH Russo A Smith CL Faraone SV Wilcox M Shafa R Glatt SJ Nguyen G Ponte JF Thiagalingam S Tsuang MT Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report Am J Med Genet B Neuropsychiatr Genet 2005 134 60 6 15717292 67 Grayson DR Jia X Chen Y Sharma RP Mitchell CP Guidotti A Costa E Reelin promoter hypermethylation in schizophrenia Proc Natl Acad Sci USA 2005 102 9341 6 15961543 68 Abdolmaleky HM Cheng KH Faraone SV Wilcox M Glatt SJ Gao F Smith CL Shafa R Aeali B Carnevale J Pan H Papageorgis P Ponte JF Sivaraman V Tsuang MT Thiagalingam S Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder Hum Mol Genet 2006 15 3132 45 16984965 69 Qiu S Korwek KM Pratt-Davis AR Peters M Bergman MY Weeber EJ Cognitive disruption and altered hippocampus synaptic function in Reelin haploin-sufficient mice Neurobiol Learn Mem 2006 85 228 42 16376115 70 Giles RH Petrij F Dauwerse HG den Hollander AI Lushnikova T van Ommen GJ Goodman RH Deaven LL Doggett NA Peters DJ Breuning MH Construction of a 1.2-Mb contig surrounding, and molecular analysis of, the human CREB-binding protein (CBP/CREBBP) gene on chromosome 16p13.3 Genomics 1997 42 96 114 9177780 71 Rouaux C Loeffler JP Boutillier AL Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders Biochem Pharmacol 2004 68 1157 64 15313413 72 Petrij F Dauwerse HG Blough RI Giles RH van der Smagt JJ Wallerstein R Maaswinkel-Mooy PD van Karnebeek CD van Ommen GJ van HA Rubinstein JH Saal HM Hennekam RC Peters DJ Breuning MH Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations J Med Genet 2000 37 168 76 10699051 73 Bartsch O Schmidt S Richter M Morlot S Seemanova E Wiebe G Rasi S DNA sequencing of CREBBP demonstrates mutations in 56% of patients with Rubinstein-Taybi syndrome (RSTS) and in another patient with incomplete RSTS Hum Genet 2005 117 485 93 16021471 74 Cantani A Gagliesi D Rubinstein-Taybi syndrome. Review of 732 cases and analysis of the typical traits Eur Rev Med Pharmacol Sci 1998 2 81 7 10229563 75 Kogan JH Frankland PW Blendy JA Coblentz J Marowitz Z Schutz G Silva AJ Spaced training induces normal long-term memory in CREB mutant mice Curr Biol 1997 7 1 11 8999994 76 Weeber EJ Sweatt JD Molecular neurobiology of human cognition Neuron 2002 33 845 8 11906692 77 Hallam TM Bourtchouladze R Rubinstein-Taybi syndrome: molecular findings and therapeutic approaches to improve cognitive dysfunction Cell Mol Life Sci 2006 63 1725 35 16786226 78 Chan HM La Thangue NB p300/CBP proteins: HATs for transcriptional bridges and scaffolds J Cell Sci 2001 114 2363 73 11559745 79 Kalkhoven E CBP and p300: HATs for different occasions Biochem Pharmacol 2004 68 1145 55 15313412 80 Oike Y Hata A Mamiya T Kaname T Noda Y Suzuki M Yasue H Nabeshima T Araki K Yamamura K Truncated CBP protein leads to classical Rubinstein-Taybi syndrome phenotypes in mice: implications for a dominant-negative mechanism Hum Mol Genet 1999 8 387 96 9949198 81 Bourtchouladze R Lidge R Catapano R Stanley J Gossweiler S Romashko D Scott R Tully T A mouse model of Rubinstein-Taybi syndrome: defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4 Proc Natl Acad Sci USA 2003 100 10518 22 12930888 82 Kazantsev A Preisinger E Dranovsky A Goldgaber D Housman D Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells Proc Natl Acad Sci USA 1999 96 11404 9 10500189 83 McCampbell A Taye AA Whitty L Penney E Steffan JS Fischbeck KH Histone deacetylase inhibitors reduce polyglutamine toxicity Proc Natl Acad Sci USA 2001 98 15179 84 11742087 84 Ferrante RJ Kubilus JK Lee J Ryu H Beesen A Zucker B Smith K Kowall NW Ratan RR Luthi-Carter R Hersch SM Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington’s disease mice J Neurosci 2003 23 9418 27 14561870 85 Gardian G Browne SE Choi DK Klivenyi P Gregorio J Kubilus JK Ryu H Langley B Ratan RR Ferrante RJ Beal MF Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington’s disease J Biol Chem 2005 280 556 63 15494404 86 Laferla FM Oddo S Alzheimer’s disease: Abeta, tau and synaptic dysfunction Trends Mol Med 2005 11 170 6 15823755 87 Blennow K de Leon MJ Zetterberg H Alzheimer’s disease Lancet 2006 368 387 403 16876668 88 Forero DA Casadesus G Perry G Arboleda H Synaptic dysfunction and oxidative stress in Alzheimer’s disease: Emerging mechanisms J Cell Mol Med 2006 10 796 805 16989739 89 Vitolo OV Sant’Angelo A Costanzo V Battaglia F Arancio O Shelanski M Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling Proc Natl Acad Sci USA 2002 99 13217 21 12244210 90 Gong B Vitolo OV Trinchese F Liu S Shelanski M Arancio O Persistent improvement in synaptic and cognitive functions in an Alzheimer mouse model after rolipram treatment J Clin Invest 2004 114 1624 34 15578094 91 Matsuzaki K Yamakuni T Hashimoto M Haque AM Shido O Mimaki Y Sashida Y Ohizumi Y Nobiletin restoring beta-amyloid-impaired CREB phosphorylation rescues memory deterioration in Alzheimer’s disease model rats Neurosci Lett 2006 400 230 4 16581185 92 Saura CA Choi SY Beglopoulos V Malkani S Zhang D Shankaranarayana Rao BS Chattarji S Kelleher RJ III Kandel ER Duff K Kirkwood A Shen J Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurode-generation Neuron 2004 42 23 36 15066262 93 Hebert SS Serneels L Tolia A Craessaerts K Derks C Filippov MA Muller U De SB Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes EMBO Rep 2006 7 739 45 16729020 94 Murr R Loizou JI Yang YG Cuenin C Li H Wang ZQ Herceg Z Histone acetylation by Trrap-Tip60 modulates loading of repair proteins and repair of DNA double-strand breaks Nat Cell Biol 2006 8 91 9 16341205 95 Blendy JA The role of CREB in depression and antide-pressant treatment Biol Psychiatry 2006 59 1144 50 16457782 96 Reppert SM Weaver DR Coordination of circadian timing in mammals Nature 2002 418 935 41 12198538 97 Doi M Hirayama J Sassone-Corsi P Circadian regulator CLOCK is a histone acetyltransferase Cell 2006 125 497 508 16678094 98 Tsankova NM Kumar A Nestler EJ Histone modifications at gene promoter regions in rat hippocampus after acute and chronic electroconvulsive seizures J Neurosci 2004 24 5603 10 15201333 99 Taniura H Sng JC Yoneda Y Histone modifications in status epilepticus induced by kainate Histol Histopathol 2006 21 785 91 16598677 100 Jongmans MC Admiraal RJ van der Donk KP Vissers LE Baas AF Kapusta L van Hagen JM Donnai D de Ravel TJ Veltman JA Geurts van KA de Vries BB Brunner HG Hoefsloot LH van Ravenswaaij CM CHARGE syndrome: the phenotypic spectrum of mutations in the CHD7 gene J Med Genet 2006 43 306 14 16155193 101 Vissers LE van Ravenswaaij CM Admiraal R Hurst JA de Vries BB Janssen IM Van DV Huys EH de Jong PJ Hamel BC Schoenmakers EF Brunner HG Veltman JA van Kessel AG Mutations in a new member of the chromodomain gene family cause CHARGE syndrome Nat Genet 2004 36 955 7 15300250 102 Woodage T Basrai MA Baxevanis AD Hieter P Collins FS Characterization of the CHD family of proteins Proc Natl Acad Sci USA 1997 94 11472 7 9326634 103 Cavalli G Paro R Chromo-domain proteins: linking chromatin structure to epigenetic regulation Curr Opin Cell Biol 1998 10 354 60 9640536 104 Roopra A Qazi R Schoenike B Daley TJ Morrison JF Localized domains of G9a-mediated histone methylation are required for silencing of neuronal genes Mol Cell 2004 14 727 38 15200951 105 Ogawa H Ishiguro K Gaubatz S Livingston DM Nakatani Y A complex with chromatin modifiers that occupies E2F- and Myc-responsive genes in G0 cells Science 2002 296 1132 6 12004135 106 Kleefstra T Brunner HG Amiel J Oudakker AR Nillesen WM Magee A Genevieve D Cormier-Daire V Van EH Fryns JP Hamel BC Sistermans EA de Vries BB van BH Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome Am J Hum Genet 2006 79 370 7 16826528 107 Gecz J The molecular basis of intellectual disability: novel genes with naturally occurring mutations causing altered gene expression in the brain Front Biosci 2004 9 1 7 14766338 108 Ropers HH X-linked mental retardation: many genes for a complex disorder Curr Opin Genet Dev 2006 16 260 9 16647850 109 Chelly J Mandel JL Monogenic causes of X-linked mental retardation Nat Rev Genet 2001 2 669 80 11533716 110 Stevenson RE Advances in X-linked mental retardation Curr Opin Pediatr 2005 17 720 4 16282777 111 Veltman JA Yntema HG Lugtenberg D Arts H Briault S Huys EH Osoegawa K de Jong P Brunner HG Geurts vK Van Bokhoven H Schoenmakers EF High resolution profiling of X chromosomal aberrations by array comparative genomic hybridisation J Med Genet 2004 41 425 32 15173227 112 Bauters M Van Esch H Marynen P Froyen G X chromosome array-CGH for the identification of novel X-linked mental retardation genes Eur J Med Genet 2005 48 263 75 16179222 113 Van Esch H Hollanders K Badisco L Melotte C Van Hummelen P Vermeesch JR Devriendt K Fryns JP Marynen P Froyen G Deletion of VCX-A due to NAHR plays a major role in the occurrence of mental retardation in patients with X-linked ichthyosis Hum Mol Genet 2005 14 1795 803 15888481 114 Van Esch H Bauters M Ignatius J Jansen M Raynaud M Hollanders K Lugtenberg D Bienvenu T Jensen LR Gecz J Moraine C Marynen P Fryns JP Froyen G Duplication of the MECP2 Region Is a Frequent Cause of Severe Mental Retardation and Progressive Neurological Symptoms in Males Am J Hum Genet 2005 77 442 53 16080119 115 Verkerk AJ Pieretti M Sutcliffe JS Fu YH Kuhl DP Pizzuti A Reiner O Richards S Victoria MF Zhang FP Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome Cell 1991 65 905 14 1710175 116 Sutcliffe JS Nelson DL Zhang F Pieretti M Caskey CT Saxe D Warren ST DNA methylation represses FMR-1 transcription in fragile X syndrome Hum Mol Genet 1992 1 397 400 1301913 117 Zalfa F Achsel T Bagni C mRNPs, polysomes or granules: FMRP in neuronal protein synthesis Curr Opin Neurobiol 2006 16 265 9 16707258 118 Coffee B Zhang F Warren ST Reines D Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells Nat Genet 1999 22 98 101 10319871 119 Coffee B Zhang F Ceman S Warren ST Reines D Histone modifications depict an aberrantly heterochroma-tinized FMR1 gene in fragile x syndrome Am J Hum Genet 2002 71 923 32 12232854 120 Gheldof N Tabuchi TM Dekker J The active FMR1 promoter is associated with a large domain of altered chromatin conformation with embedded local histone modifications Proc Natl Acad Sci USA 2006 103 12463 8 16891414 121 Pietrobono R Tabolacci E Zalfa F Zito I Terracciano A Moscato U Bagni C Oostra B Chiurazzi P Neri G Molecular dissection of the events leading to inactivation of the FMR1 gene Hum Mol Genet 2005 14 267 77 15563507 122 Yan QJ Rammal M Tranfaglia M Bauchwitz RP Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP Neuropharmacology 2005 49 1053 66 16054174 123 McBride SM Choi CH Wang Y Liebelt D Braunstein E Ferreiro D Sehgal A Siwicki KK Dockendorff TC Nguyen HT McDonald TV Jongens TA Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome Neuron 2005 45 753 64 15748850 124 Hanefeld F Hagberg B Percy A Molecular and neurobiology aspects of Rett syndrome Neuropediatrics 1995 26 60 1 7566452 125 Hagberg B Hanefeld F Percy A Skjeldal O An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome clinical criteria consensus panel satellite to European paediatric neurology Society meeting, Baden Baden, Germany, 11 September 2001 Eur J Paediatr Neurol 2002 6 293 7 12378695 126 Neul JL Zoghbi HY Rett syndrome: a prototypical neu-rodevelopmental disorder Neuroscientist 2004 10 118 28 15070486 127 Collins AL Levenson JM Vilaythong AP Richman R Armstrong DL Noebels JL David SJ Zoghbi HY Mild overexpression of MeCP2 causes a progressive neurological disorder in mice Hum Mol Genet 2004 13 2679 89 15351775 128 Luikenhuis S Giacometti E Beard CF Jaenisch R Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice Proc Natl Acad Sci USA 2004 101 6033 8 15069197 129 Bienvenu T Chelly J Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized Nat Rev Genet 2006 7 415 26 16708070 130 Martinowich K Hattori D Wu H Fouse S He F Hu Y Fan G Sun YE DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation Science 2003 302 890 3 14593184 131 Chen WG Chang Q Lin Y Meissner A West AE Griffith EC Jaenisch R Greenberg ME Derepression of BDNF transcription involves calcium-dependent phos-phorylation of MeCP2 Science 2003 302 885 9 14593183 132 Samaco RC Hogart A LaSalle JM Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3 Hum Mol Genet 2005 14 483 92 15615769 133 Makedonski K Abuhatzira L Kaufman Y Razin A Shemer R MeCP2 deficiency in Rett syndrome causes epigenetic aberrations at the PWS/AS imprinting center that affects UBE3A expression Hum Mol Genet 2005 14 1049 58 15757975 134 Nuber UA Kriaucionis S Roloff TC Guy J Selfridge J Steinhoff C Schulz R Lipkowitz B Ropers HH Holmes MC Bird A Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome Hum Mol Genet 2005 14 2247 56 16002417 135 Horike S Cai S Miyano M Cheng JF Kohwi-Shigematsu T Loss of silent-chromatin looping and impaired imprinting of DLX5 in Rett syndrome Nat Genet 2005 37 31 40 15608638 136 Kriaucionis S Paterson A Curtis J Guy J Macleod N Bird A Gene expression analysis exposes mitochondrial abnormalities in a mouse model of Rett syndrome Mol Cell Biol 2006 26 5033 42 16782889 137 Peddada S Yasui DH LaSalle JM Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome Hum Mol Genet 2006 15 2003 14 16682435 138 Colantuoni C Jeon OH Hyder K Chenchik A Khimani AH Narayanan V Hoffman EP Kaufmann WE Naidu S Pevsner J Gene expression profiling in postmortem Rett Syndrome brain: differential gene expression and patient classification Neurobiol Dis 2001 8 847 65 11592853 139 Johnston MV Jeon OH Pevsner J Blue ME Naidu S Neurobiology of Rett syndrome: a genetic disorder of synapse development Brain Dev 2001 23 S206 13 11738874 140 Gibbons RJ Picketts DJ Villard L Higgs DR Mutations in a putative global transcriptional regulator cause X-linked mental retardation with alpha-thalassemia (ATR-X syndrome) Cell 1995 80 837 45 7697714 141 Cardoso C Timsit S Villard L Khrestchatisky M Fontes M Colleaux L Specific interaction between the XNP/AsTR-X gene product and the SET domain of the human EZH2 protein Hum Mol Genet 1998 7 679 84 9499421 142 Berube NG Mangelsdorf M Jagla M Vanderluit J Garrick D Gibbons RJ Higgs DR Slack RS Picketts DJ The chromatin-remodeling protein ATRX is critical for neuronal survival during corticogenesis J Clin Invest 2005 115 258 67 15668733 143 Xue Y Gibbons R Yan Z Yang D McDowell TL Sechi S Qin J Zhou S Higgs D Wang W The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies Proc Natl Acad Sci USA 2003 100 10635 40 12953102 144 Gibbons RJ McDowell TL Raman S O’Rourke DM Garrick D Ayyub H Higgs DR Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation Nat Genet 2000 24 368 71 10742099 145 Garrick D Sharpe JA Arkell R Dobbie L Smith AJ Wood WG Higgs DR Gibbons RJ Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues PLoS Genet 2006 2 e58 16628246 146 Hanauer A Young ID Coffin-Lowry syndrome: clinical and molecular features J Med Genet 2002 39 705 13 12362025 147 Sassone-Corsi P Mizzen CA Cheung P Crosio C Monaco L Jacquot S Hanauer A Allis CD Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3 Science 1999 285 886 91 10436156 148 De Cesare D Jacquot S Hanauer A Sassone-Corsi P Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene Proc Natl Acad Sci USA 1998 95 12202 7 9770464 149 Merienne K Pannetier S Harel-Bellan A Sassone-Corsi P Mitogen-regulated RSK2-CBP interaction controls their kinase and acetylase activities Mol Cell Biol 2001 21 7089 96 11564891 150 Martens JH Verlaan M Kalkhoven E Zantema A Cascade of distinct histone modifications during collage-nase gene activation Mol Cell Biol 2003 23 1808 16 12588998 151 Jensen LR Amende M Gurok U Moser B Gimmel V Tzschach A Janecke AR Tariverdian G Chelly J Fryns JP Van Esch H Kleefstra T Hamel B Moraine C Gecz J Turner G Reinhardt R Kalscheuer VM Ropers HH Lenzner S Mutations in the JARIDIC gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation Am J Hum Genet 2005 76 227 36 15586325 152 Shoichet SA Hoffmann K Menzel C Trautmann U Moser B Hoeltzenbein M Echenne B Partington M van BH Moraine C Fryns JP Chelly J Rott HD Ropers HH Kalscheuer VM Mutations in the ZNF41 gene are associated with cognitive deficits: identification of a new candidate for X-linked mental retardation Am J Hum Genet 2003 73 1341 54 14628291 153 Kleefstra T Yntema HG Oudakker AR Banning MJ Kalscheuer VM Chelly J Moraine C Ropers HH Fryns JP Janssen IM Sistermans EA Nillesen WN de Vries LB Hamel BC van BH Zinc finger 81 (ZNF81) mutations associated with X-linked mental retardation J Med Genet 2004 41 394 9 15121780 154 Lugtenberg D Yntema HG Banning MJ Oudakker AR Firth HV Willatt L Raynaud M Kleefstra T Fryns JP Ropers HH Chelly J Moraine C Gecz J Reeuwijk J Nabuurs SB de Vries BB Hamel BC de Brouwer AP Bokhoven H ZNF674: A new Kruppel-associated box-containing zinc-finger gene involved in nonsyndromic X-linked mental retardation Am J Hum Genet 2006 78 265 78 16385466 155 Schultz DC Ayyanathan K Negorev D Maul GG Rauscher FJ III SETDB1: a novel KAP-1-associated histone H3, lysine 9-specific methyltransferase that contributes to HP1-mediated silencing of euchromatic genes by KRAB zinc-finger proteins Genes Dev 2002 16 919 32 11959841 156 Sripathy SP Stevens J Schultz DC 2006 The KAP1 core-pressor functions to coordinate the assembly of de novo HP1 demarcated microenvironments of heterochromatin required for KRAB zinc finger protein mediated transcrip-tional repression Mol Cell Biol ; Epub ahead of publication 157 Ng D Thakker N Corcoran CM Donnai D Perveen R Schneider A Hadley DW Tifft C Zhang L Wilkie AO van der Smagt JJ Gorlin RJ Burgess SM Bardwell VJ Black GC Biesecker LG Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR Nat Genet 2004 36 411 6 15004558 158 van LF van SB Histone modifications: from genome-wide maps to functional insights Genome Biol 2005 6 113 15960810 159 van Steensel B Mapping of genetic and epigenetic regulatory networks using microarrays Nat Genet 2005 37 S18 24 15920525 160 Wade PA Gegonne A Jones PL Ballestar E Aubry F Wolffe AP Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation Nat Genet 1999 23 62 6 10471500 161 Sarraf SA Stancheva I Methyl-CpG binding protein MBD1 couples histone H3 methylation at lysine 9 by SETDB1 to DNA replication and chromatin assembly Mol Cell 2004 15 595 605 15327775 162 Kaufmann WE Jarrar MH Wang JS Lee YJ Reddy S Bibat G Naidu S Histone modifications in Rett syndrome lymphocytes: a preliminary evaluation Brain Dev 2005 27 331 9 16023547 163 Lachner M O’Sullivan RJ Jenuwein T An epigenetic road map for histone lysine methylation J Cell Sci 2003 116 2117 24 12730288 164 Wilson IM Davies JJ Weber M Brown CJ Alvarez CE MacAulay C Schubeler D Lam WL Epigenomics: mapping the methylome Cell Cycle 2006 5 155 8 16397413 165 Heisler LE Torti D Boutros PC Watson J Chan C Winegarden N Takahashi M Yau P Huang TH Farnham PJ Jurisica I Woodgett JR Bremner R Penn LZ Der SD CpG Island microarray probe sequences derived from a physical library are representative of CpG Islands annotated on the human genome Nucleic Acids Res 2005 33 2952 61 15911630 166 Weber M Davies JJ Wittig D Oakeley EJ Haase M Lam WL Schubeler D Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells Nat Genet 2005 37 853 62 16007088 167 Hinds DA Stuve LL Nilsen GB Halperin E Eskin E Ballinger DG Frazer KA Cox DR Whole-genome patterns of common DNA variation in three human populations Science 2005 307 1072 9 15718463 168 McCarroll SA Hadnott TN Perry GH Sabeti PC Zody MC Barrett JC Dallaire S Gabriel SB Lee C Daly MJ Altshuler DM Common deletion polymorphisms in the human genome Nat Genet 2006 38 86 92 16468122 169 Hinds DA Kloek AP Jen M Chen X Frazer KA Common deletions and SNPs are in linkage disequilibrium in the human genome Nat Genet 2006 38 82 5 16327809 170 Conrad DF Andrews TD Carter NP Hurles ME Pritchard JK A high-resolution survey of deletion polymorphism in the human genome Nat Genet 2006 38 75 81 16327808 171 Feuk L Carson AR Scherer SW Structural variation in the human genome Nat Rev Genet 2006 7 85 97 16418744",
  "plain_text": "The search for the genetic defects in constitutional diseases has so far been restricted to direct methods for the identification of genetic mutations in the patients’ genome. Traditional methods such as karyotyping, FISH, mutation screening, positional cloning and CGH, have been complemented with newer methods including array-CGH and PCR-based approaches (MLPA, qPCR). These methods have revealed a high number of genetic or genomic aberrations that result in an altered expression or reduced functional activity of key proteins. For a significant percentage of patients with congenital disease however, the underlying cause has not been resolved strongly suggesting that yet other mechanisms could play important roles in their etiology. Alterations of the ‘native’ epigenetic imprint might constitute such a novel mechanism. Epigenetics, heritable changes that do not rely on the nucleotide sequence, has already been shown to play a determining role in embryonic development, X-inactivation, and cell differentiation in mammals. Recent progress in the development of techniques to study these processes on full genome scale has stimulated researchers to investigate the role of epigenetic modifications in cancer as well as in constitutional diseases. We will focus on mental impairment because of the growing evidence for the contribution of epigenetics in memory formation and cognition. Disturbance of the epigenetic profile due to direct alterations at genomic regions, or failure of the epigenetic machinery due to genetic mutations in one of its components, has been demonstrated in cognitive derangements in a number of neurological disorders now. It is therefore tempting to speculate that the cognitive deficit in a significant percentage of patients with unexplained mental retardation results from epigenetic modifications."
}
